Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression in schizophrenia.

R E Becker1

  • 1Department of Psychiatry, Southern Illinois University School of Medicine, Springfield 62794.

Hospital & Community Psychiatry
|December 1, 1988
PubMed
Summary
This summary is machine-generated.

Depression in schizophrenia is poorly understood and linked to worse outcomes. Antidepressant medications are not effective for treating this secondary depression in schizophrenic patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distribution of Vibrio cholerae in the Apalachicola (Florida) Bay Estuary.

Journal of food protection·2019
Same author

Non-O1 Vibrio cholerae in Shellfish, Sediment and Waters of the U.S. Gulf Coast.

Journal of food protection·2019
Same author

Effect of monoamine oxidase A and B inhibition on the uptake and metabolism of serotonin within serotonergic neurons of rat brain.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Why so few drugs for Alzheimer's disease? Are methods failing drugs?

Current Alzheimer research·2010
Same author

Effects of time and cholinesterase inhibitor treatment on multiple cerebrospinal fluid parameters in Alzheimer's disease.

Methods and findings in experimental and clinical pharmacology·1999
Same author

Employment outcomes for clients with severe mental illness in a PACT model replication. Program for Assertive Community Treatment.

Psychiatric services (Washington, D.C.)·1999
Same journal

Multiple personality.

Hospital & community psychiatry·1994
Same journal

How to treat inpatients.

Hospital & community psychiatry·1994
Same journal

Folie à deux in identical twins.

Hospital & community psychiatry·1994
Same journal

Psychiatrists' and patients' views on drug information sources and medication compliance.

Hospital & community psychiatry·1994
Same journal

Factors related to psychiatric consultation for schizophrenic patients receiving medical care.

Hospital & community psychiatry·1994
Same journal

An inpatient team's response to alleged sexual misconduct by an outpatient psychotherapist.

Hospital & community psychiatry·1994
See all related articles

Area of Science:

  • Psychiatry
  • Clinical Psychology

Background:

  • Depressive syndromes complicating schizophrenia lack clear understanding and diagnostic criteria.
  • This ambiguity contributes to underestimation of its frequency and impact on patient outcomes.
  • Secondary depression in schizophrenia is associated with impaired functioning, relapse, and suicide risk.

Purpose of the Study:

  • To review the literature on depression secondary to schizophrenia.
  • To clarify the frequency, diagnostic challenges, and clinical implications of depressive syndromes in schizophrenia.
  • To provide evidence-based recommendations for clinical management.

Main Methods:

  • Systematic literature review of studies on depression in schizophrenia.
  • Analysis of diagnostic criteria and their limitations.

Related Experiment Videos

  • Evaluation of outcome data and treatment efficacy.

    • Main Results:

    • Lack of validated diagnostic criteria hinders accurate assessment of secondary depression in schizophrenia.
    • Evidence does not support the concept of postpsychotic depression.
    • Secondary depression is linked to poor psychosocial functioning, increased relapse rates, and elevated suicide risk.
    • Antidepressant medications show limited efficacy for secondary depression in schizophrenia.

    Conclusions:

    • Accurate diagnosis and differential diagnosis, excluding akinetic depression, are crucial.
    • Clinical management must prioritize addressing risks of relapse and suicide.
    • Current evidence suggests antidepressant pharmacotherapy is not effective for secondary depression in schizophrenia.